October 5, 2016 / 3:12 PM / 10 months ago

BRIEF-Teva announces sale of UK and Ireland actavis assets and operations

1 Min Read

Oct 5 (Reuters) - Teva Pharmaceutical Industries Ltd

* Teva announces sale of UK and Ireland actavis assets and operations

* Deal for GBP 603 million

* Sale will include a portfolio of generic medicines plus a manufacturing plant in Barnstaple, England

* Teva retains a number of actavis non-overlapping generic products plus certain specialty medicines and otc products

* Greenhill & Co. are serving as financial advisors to Teva, and Pinsent Masons are serving as legal counsel to Teva in respect of this transaction

* Divestment of certain specified actavis generics assets and operations in UK and Ireland was part of an undertaking that Teva made to European commission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below